#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital absence of bile ducts Hypochromic anaemia Congenital hypotransferrinaemia Liver abscess Deafness neurosensory Synovitis Pouchitis Intracranial calcification Gaucher's disease type III Myasthenia gravis Aspergillus infection Primary immunodeficiency syndrome Small intestine neuroendocrine tumour Stiff person syndrome Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Diagnostics Haemophagocytic lymphohistiocytosis – Diagnostics Retinitis pigmentosa Hereditary hypophosphataemic rickets – Basic Information Leiomyosarcoma recurrent – Life with Disease Bronchopulmonary dysplasia Piriformis syndrome – Diagnostics Choroid melanoma – Basic Information Primary immunodeficiency syndrome – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Immunoglobulin A Mebeverine Hydrochloride Dl-Alpha-Tocopherol Gskvx000000008885 Masupirdine Relugolix Ferric Carboxymaltose Pegipanermin Soya-Bean Oil Refined Piromelatine Treprostinil Histamine Hydrochloride Paracetamol Izorlisib Mesilate Eptacog Beta (Activated) Cangrelor Tetrasodium Betamethasone Dipropionate A3907 Tetracycline Hydrochloride Rifampicin More therapies…

    Learn about Your Condition

    Chondroplasty Plasma cell myeloma recurrent Hidradenitis Postoperative delirium Metastases to biliary tract Pancreaticoduodenectomy Metastases to liver Tuberous sclerosis complex Psychological trauma Iron overload Metastatic glioma Insomnia Stomatitis Immunosuppression Skin bacterial infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Brigatinib for Children and Young Adults with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, or Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Brigatinib
    Austria Belgium Czechia Denmark Finland France +7

  • Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Poland

  • Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Tenecteplase
    • Acetylsalicylic Acid
    • Sodium Chloride
    Belgium Denmark Finland Ireland Norway Sweden

  • Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Cyclophosphamide
    • Paclitaxel
    France

  • Evaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nandrolone Decanoate
    • Sodium Chloride
    Poland

  • Study on Reducing Antibiotic Use in Severe COPD Exacerbation with Amoxicillin, Cefotaxime, and Ciprofloxacin for Patients on Mechanical Ventilation or Oxygen Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Spiramycin
    • Amoxicillin Sodium
    • Cefepime Hydrochloride
    France
Previous Page
1 … 398 399 400 401 402 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!